Deaconess News

The Women’s Hospital has named C. Brennan Fitzpatrick, MD, MBA, FACOG, to the role of the first Chief Medical Officer at The Women’s Hospital.
04/13/2021

To protect vulnerable patients receiving care in our hospitals and clinics, Deaconess will continue to require face masks within our facilities until further notice.
04/05/2021

For the fourth year in a row, Deaconess Health System’s Next Generation Accountable Care Organization (ACO), Deaconess Care Integration (DCI), has achieved shared saving with the Centers for Medicare and Medicaid Services (CMS) Next Generation ACO Model.
03/12/2021

Deaconess today announced that it has achieved the Healthgrades 2021 America’s 250 Best Hospitals Award™. The distinction places Deaconess Hospital in the top five percent of nearly 4,500 hospitals assessed across the U.S. 
03/04/2021

Tri-State first responders were presented with 17 automated external defibrillators (AEDs) in the Pavilion, located inside the Orthopedic & Neuroscience Hospital on the Deaconess Gateway Campus.
 
02/24/2021

The following locations have been affected by the current winter weather conditions. 
02/18/2021

Two new faces have joined the senior administrative team at Deaconess. JoAnn Wood, MD, MSME, MHA, AAP, ACP, became Vice President, Chief Medical Officer in September, 2020.  Jennifer Chiusano, MA, BSN, RN, NE-BC, began serving as Vice President and Chief Nurse Executive in January, 2021.
02/16/2021

Deaconess has been named a Level 9 ‘Most Wired’ healthcare organization for the first time, after being on the ‘Most Wired’ list for 9 consecutive years. Only 71 hospitals nationwide received this level of recognition from the College of Healthcare Information Management Executives (CHIME), as part of the organization’s 2020 Healthcare’s Most Wired program.
 
02/08/2021

Deaconess Health System held a groundbreaking ceremony today for a new GI Center. It will be located on the Deaconess Gateway Campus.  
11/18/2020

Deaconess has received an allotment of bamlanivimab, a newly-released monoclonal antibody treatment for COVID-19. Select high risk COVID-19 patients will be able to receive it. 
11/17/2020